The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
Marilyn Heng(Harvard University), Akihiko Matsumine(University of Fukui), Robart Nakayama, Andrew J. Bishop(The University of Texas MD Anderson Cancer Center), Santiago A. Lozano‐Calderón(Harvard University), Toshifumi Ozaki(Okayama University), Tomoki Nakamura(Mie University), Patrick P. Lin(The University of Texas MD Anderson Cancer Center), Hideo Morioka, Shigeki Kakunaga(Osaka International Cancer Institute), Akihito Nagano(Gifu University), John H. Healey(Memorial Sloan Kettering Cancer Center), Makoto Emori, Ginger E. Holt(Vanderbilt University Medical Center), Matthew T. Houdek(Mayo Clinic), Ilkyu Han(Seoul National University Hospital), Mitsunori Kaya, Max Vaynrub(Memorial Sloan Kettering Cancer Center), Norio Yamamoto, Peter C. Ferguson(Mount Sinai Hospital), Akira Kawai(GTx (United States)), Koji Hiraoka, Abha A. Gupta(Roche (Switzerland)), Teruki Kidani, Hiroyuki Tsuchiya(Kanazawa University), T. Akiyama, Takatoshi Ohno, Xiaohui Niu(Peking University), Motohiro Kawasaki, Yasuo Yazawa, Takafumi Ueda(The University of Osaka), Hideshi Sugiura, Toshiyuki Kunisasa, Tabu Gokita, Francis J. Hornicek(University of Miami), Tomoaki Torigoe, Peter S. Rose(Mayo Clinic in Arizona), Yoshiki Yamagami, Takashi Yanagawa, Yoshihiro Matsumoto(Jikei University Kashiwa hospital), Shoji Simose, David Biau(Délégation Paris 5), Tetsuji Yamamoto(Kagawa University Hospital), Peter Chung(Princess Margaret Cancer Centre), Yen‐Lin Evelyn Chen(Harvard University), Keisuke Ae, Jun Manabe, Jay S. Wunder(Sinai Hospital), Tadahiko Kubo(Hiroshima University), Nicholas M. Bernthal(Harvard University)
Cited by 79
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2020|482